« Studies Show Massage Relieves Symptoms Of Many Conditions | Main | IVAX, Serono say oral cladribine trials for MS positive »

Biogen Idec, Elan to submit MS drug for European approval

Biogen Idec and Elan Corp. plc said Tuesday that they plan to submit their multiple sclerosis drug Antegren for approval in Europe.

The filing will be made to the European Agency for the Evaluation of Medicinal Products in the summer of 2004.

More here.

March 23, 2004 in antegren , economy, follow the money..., stocks, tysabri | Permalink

Comments